Evidence map›Paper›PMID 11773402›Full record

ArticleJournal of virology2002

Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.

Nicole Pavio, Deborah R Taylor, Michael M C Lai

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Chaperones in hepatitis C virus infection.World journal of hepatology · 2016
    Review
  7. Review
  8. Review
  9. The role of chemokines in hepatitis C virus-mediated liver disease.International journal of molecular sciences · 2014
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicole PavioHoward Hughes Medical Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Deborah R Taylor
Michael M C Lai
University of Southern California · USHoward Hughes Medical Institute · US

Funding

TRANSGENIC MICE AS A MODEL TO STUDY HEPATITIS C VIRUS IMMUNOPATHOGENESISU19AI040038 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, MICHAEL M.C. · 1996 to 2004
$3.8M
NIAID NIH HHS AI 40038NIAID NIH HHS N01 AI040038
6 · The paper itself

Abstract

The hepatitis C virus (HCV) envelope protein E2 has been shown to accumulate in the lumen of the endoplasmic reticulum (ER) as a properly folded glycoprotein as well as large aggregates of misfolded proteins. In the present study, we have identified an additional unglycosylated species, with an apparent molecular mass of 38 kDa (E2-p38). In contrast to the glycosylated E2, E2-p38 is significantly less stable and is degraded through the proteasome pathway. Correspondingly, E2-p38 is found to be ubiquitinated. E2-p38 is localized mostly in the cytosol, in contrast to the glycosylated form, which is exclusively membrane associated. Alpha interferon (IFN-alpha) treatment or overexpression of the double-stranded RNA-activated protein kinase (PKR) significantly increased the stability of E2-p38, consistent with a previous report (D. R. Taylor, S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai, Science 285:107-110, 1999) that E2 interacts with PKR and inhibits its kinase activity. Direct interaction between PKR and E2-p38, but not the glycosylated form of E2, was also observed. These results show that E2-p38 is the form of E2 that interacts with PKR in the cytosol and may contribute to the resistance of HCV to IFN-alpha. Thus, an ER protein can exist in the cytosol as an unglycosylated species and impair cellular functions.

Indexed as

Cell Line, TransformedCell MembraneCysteine EndopeptidasesCytosoleIF-2 KinaseGlycosylationHeLa CellsHepacivirusHumansInterferon-gammaMultienzyme ComplexesProteasome Endopeptidase ComplexSubcellular FractionsUbiquitinViral Envelope ProteinsCysteine EndopeptidaseseIF-2 Kinaseglycoprotein E2, Hepatitis C virusInterferon-gammaMultienzyme ComplexesProteasome Endopeptidase ComplexUbiquitinViral Envelope Proteins

Identifiers

PMID11773402
PMCPMC135859
OpenAlexW2104201232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.